Financial Daily

Europe-based pharmaceuticals groups are outperforming United States and Japanese rivals in efforts to ensure medicines reach the poor, says an independent evaluation published by the Financial Times. GSK a UK-based pharmaceutical company retained its prime position in second Access to Medicines Index, Merck of US, known for its efforts on HIV and donations to treat river blindness, came next, ahead of Novartis, Gilead and Sanofi-Aventis.